ATNM
Actinium Pharmaceuticals Inc
1.20$
+0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | 100.0% | – | – | 100.0% | 100.0% | |
| – | 245.7% | – | – | – | 25.2% | – | – | 228.9% | – | – | – | – | |
| – | -145.7% | – | – | – | -25.2% | – | – | 100.0% | – | – | 100.0% | 101.1% | |
| – | 9,776.5% | – | – | – | 568.8% | – | – | 4,720.0% | – | – | 15.4% | 53.4% | |
| – | 2,846.9% | – | – | – | 332.6% | – | – | 1,704.4% | – | – | 5.9% | 21.1% | |
| – | 12,623.5% | – | – | – | 901.4% | – | – | 6,424.4% | – | – | 21.2% | 73.9% | |
| – | -12,769.1% | – | – | – | -926.5% | – | – | -6,324.4% | – | – | 78.8% | 27.2% | |
| – | 675.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11,511.1% | – | – | – | -821.2% | – | – | -5,701.1% | – | – | 79.7% | 32.2% | |
| – | 675.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11,511.1% | – | – | – | -821.2% | – | – | -5,701.1% | – | – | 79.7% | 32.2% | |
| – | -11,265.4% | – | – | – | -796.0% | – | – | -5,472.2% | – | – | 80.4% | 34.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.